OCALIVA
Identification of Ocaliva
| No description |
Google image searchProduct monograph
Active ingredient
obeticholic acid, 5 MG
DIN: 02463121
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: ADVANZ PHARMA CANADA INC.
Date: 08-DEC-2023
ATC:
- A05 — BILE AND LIVER THERAPY (ATC, ATC/DDD, )
- A05A — BILE THERAPY (ATC, ATC/DDD)
- A05AA — Bile acid preparations (ATC, ATC/DDD)
- A05AA04 — OBETICHOLIC ACID (ATC/DDD)
Reference brand drug: Ocaliva
